Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
151 |
|
| Actual shortage: | 5 (3%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 140 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEGRETOL | 200MG | TABLET | Resolved | 2019-03-20 | 2019-07-23 | 79017 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-03-27 | 79064 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-13 | 79071 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79076 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79079 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-04-08 | 2019-04-26 | 80771 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-29 | 2019-08-12 | 82741 |
| PATADAY | 0.2% | SOLUTION | Resolved | 2019-05-07 | 2019-06-19 | 83364 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-05-07 | 2020-09-08 | 83368 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-06-05 | 2019-08-02 | 85629 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-06-21 | 2019-09-06 | 87200 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2019-08-13 | 2019-11-07 | 91488 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-25 | 2020-02-04 | 94696 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2019-10-25 | 2020-02-27 | 97281 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-11-08 | 2019-12-19 | 98249 |
| DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2019-11-15 | 2020-01-06 | 98922 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Resolved | 2019-12-03 | 2020-03-09 | 100125 |
| DIOVAN 80MG TABLETS | 80MG | TABLET | Resolved | 2019-12-16 | 2020-03-27 | 101436 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2019-12-16 | 2019-12-19 | 101440 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |